Abstract:Purpose High-intensity focused ultrasound (HIFU)-mediated drug release becomes a promising therapeutic technique for treatment of cancer, which has merits of deep penetration, noninvasive approach and nonionizing radiation. However, conventional thermocouple-based approach for treatment monitoring would encounter big challenges such as the viscous heating artifact and difficulty in monitoring in the deep region. In this study, we develop an effective method based on thermal strain imaging (TSI) for the evaluation of HIFU-mediated drug release. Methods Both phantom experiments and preliminary animal experiments were performed to investigate the feasibility of the proposed approach. Doxorubicin (DOX)-loaded cerasomes (HIFU and temperature-sensitive cerasomes, HTSCs) were prepared. In the phantom experiments, the HTSC solution is contained inside a cylindrical chamber within a tissue-mimicking phantom. In the animal experiments, the HTSCs are intravenously injected into tumor-bearing mice. An HIFU transducer is used to trigger DOX release from the HTSCs within the phantom or mice, and TSI is performed during HIFU heating. In the phantom experiments, the accuracy of temperature estimation using TSI is validated by measuring with a thermocouple. In animal experiments, the spatial consistency between the distribution of DOX released within the tumor and the location of the heating region estimated by TSI is validated using a spectrofluorophotometer. Results In the phantom experiments, the HTSCs show a burst release of DOX when the temperature of the HTSC solution estimated by TSI reaches about 42 degrees C, which is in agreement with the condition for drug release from the HTSCs. The temperature estimation using TSI has high accuracy with error below 2.5%. In animal experiments, fluorescence imaging of the tumor validates that the heating region of HIFU could be localized by the low-strain region of TSI. Conclusion The present framework demonstrates a reliable and effective solution to the evaluation of HIFU-mediated local drug delivery.

Controlled Thermal-Sensitive Liposomes Release on a Disposable Microfluidic Device

A Disposable Microfluidic Device for Controlled Drug Release from Thermal-Sensitive Liposomes by High Intensity Focused Ultrasound

The Enhanced HIFU-induced Thermal Effect Via Magnetic Ultrasound Contrast Agent Microbubbles.

A Continuous Tri-Phase Transition Effect for Hifu-Mediated Intravenous Drug Delivery

Evaluating HIFU-Mediated Local Drug Release Using Thermal Strain Imaging: Phantom and Preliminary in-vivo Studies.

Large-Volume Hyperthermia for Safe and Cost-Effective Targeted Drug Delivery Using a Clinical Ultrasound-Guided Focused Ultrasound Device

Nanohybrid Liposomal Cerasomes with Good Physiological Stability and Rapid Temperature Responsiveness for High Intensity Focused Ultrasound Triggered Local Chemotherapy of Cancer.

Hyperthermia-triggered drug delivery from iRGD-modified temperature-sensitive liposomes enhances the anti-tumor efficacy using high intensity focused ultrasound

Focused ultrasound influence on calcein-loaded thermosensitive stealth liposomes

Localised drug release using MRI-controlled focused ultrasound hyperthermia

Ultrasound triggered, image guided, local drug delivery

Spatiotemporal Drug Delivery Using Laser-Generated-focused Ultrasound System

Pilot Study On Combined Cancer Therapy By Thermo-Sensitive Liposomes And Ultrasound Phased Arrays Induced Heating

Enhancement of liposome delivery efficiency via cell membrane permeability by ultrasound exposure

Preparation of PEG-S-PLA Micelles and the HIFU Controlled Release Behavior

Biocompatible magnetic liposomes for temperature triggered drug delivery.

Real-time Imaging-Guided Microbubble Mediated High Intensity Focused Ultrasound Heating in an Ex-Vivo Machine-Perfused Pig Liver

Stepwise drug release from a nanoplatform under MR-assisted focused ultrasound stimulation

Ultrasound Triggered Drug Release from 10-Hydroxycamptothecin-loaded Phospholipid Microbubbles for Targeted Tumor Therapy in Mice.

Ultrasound-Responsive Liposomes for Targeted Drug Delivery Combined with Focused Ultrasound

Temperature and Ultrasound-Responsive Nanoassemblies for Enhanced Organ Targeting and Reduced Cardiac Toxicity